Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Suarez (Palma de Mallorca, Spain), J. Sauleda Roig (Palma de Mallorca, Spain), N. Calvo Rado (Palma de Mallorca, Spain), S. Hermoso De Mendoza Aristegui (Palma de Mallorca, Spain), L. Ramon Clar (Palma de Mallorca, Spain), B. Nuñez Sanchez (Palma de Mallorca, Spain), A. Iglesias Coma (Palma de Mallorca, Spain), L. Noje Noje (Palma de Mallorca, Spain), A. Alonso Fernandez (Palma de Mallorca, Spain), D. Morell García (Palma de Mallorca, Spain), M. Rodriguez Romero (Palma de Mallorca, Spain), N. Toledo Pons (Palma de Mallorca, Spain), J. Valera Felices (Palma de Mallorca, Spain), J. Martinez Menendez (Palma de Mallorca, Spain), J. Palmer Sancho (Palma de Mallorca, Spain), J. Pons De Ves (Palma de Mallorca, Spain), E. Sala Llinas (Palma de Mallorca, Spain). Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia. 728

Member's Comments

No comment yet.

Related content which might interest you: Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Biomarkers for pulmonary hypertension in interstitial lung disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Systemic autoimmunity and  pulmonary fibrosis Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010